John P Clancy Selected Research

John P Clancy Research Topics

Disease

48	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 11/2003
13	Lung Diseases (Lung Disease) 01/2022 - 10/2013
8	Inflammation (Inflammations) 11/2020 - 02/2006
8	Infections 10/2020 - 04/2014
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2009
2	Pneumonia (Pneumonitis) 11/2018 - 04/2014
2	Fibrosis (Cirrhosis) 01/2018 - 12/2016
2	Acute Kidney Injury (Acute Renal Failure) 10/2015 - 07/2014
2	Pseudomonas Infections 01/2015 - 05/2014
1	High-Frequency Hearing Loss 10/2021
1	Dehydration (Water Stress) 01/2019
1	Joint Diseases (Joint Disease) 01/2019
1	Exocrine Pancreatic Insufficiency 01/2019
1	Asthma (Bronchial Asthma) 12/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2018
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Idiopathic Pulmonary Fibrosis 12/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2018
1	Sepsis (Septicemia) 12/2018
1	Pulmonary Arterial Hypertension 12/2018
1	Airway Remodeling 01/2018
1	Disease Progression 01/2018
1	Bronchopneumonia 01/2017
1	Bronchiolitis Obliterans 12/2016
1	Bronchiectasis 12/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2016
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2015
1	Respiratory Syncytial Virus Infections 04/2014
1	Osteolysis 08/2011
1	Bone Resorption 08/2011

Drug/Important Bio-Agent (IBA)

13	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021 - 02/2006
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2007
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
5	AminoglycosidesIBA 10/2021 - 07/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2016 - 12/2006
4	ivacaftorIBA 01/2022 - 10/2013
4	ChloridesIBA 01/2022 - 11/2003
2	elexacaftorIBA 01/2022 - 01/2021
2	lumacaftorIBA 01/2022 - 01/2021
2	ivacaftor drug combination tezacaftorIBA 01/2022 - 01/2021
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2021 - 11/2018
2	Protons (Proton)IBA 11/2020 - 01/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 12/2016
2	SodiumIBA 11/2018 - 07/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 01/2014
2	CytokinesIBA 01/2018 - 08/2011
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2016 - 12/2006
2	Amikacin (A.M.K)FDA LinkGeneric 01/2015 - 05/2014
2	Nonsense Codon (Nonsense Mutation)IBA 01/2009 - 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	CeramidesIBA 10/2020
1	EnzymesIBA 10/2020
1	SphingolipidsIBA 10/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2020
1	Acid CeramidaseIBA 10/2020
1	Antisense OligonucleotidesIBA 01/2019
1	eluforsenIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Methicillin (Metin)FDA Link 01/2019
1	MucinsIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Ribosomal DNA (rDNA)IBA 11/2017
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2017
1	ElastinIBA 12/2016
1	Expectorants (Mucolytics)IBA 12/2016
1	CollagenIBA 12/2016
1	Contrast MediaIBA 11/2016
1	human GAA protein (Myozyme)FDA Link 04/2015
1	CreatinineIBA 07/2014
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2014
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2014
1	Matrix Metalloproteinases (MMPs)IBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	Peroxidase (Myeloperoxidase)IBA 04/2014
1	Chloride Channels (Chloride Channel)IBA 01/2014
1	camostatIBA 07/2013
1	prostasinIBA 07/2013
1	Biological ProductsIBA 10/2012
1	ElementsIBA 10/2012
1	LigandsIBA 08/2011
1	NucleosidesIBA 08/2011
1	atalurenIBA 01/2009
1	Terminator Codon (Termination Codon)IBA 01/2009
1	Complementary DNA (cDNA)IBA 08/2007
1	AMP-Activated Protein KinasesIBA 02/2006
1	AerosolsIBA 02/2004
1	NucleotidesIBA 11/2003
1	imidazoleIBA 11/2003
1	SRI 2931IBA 11/2003

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2003
3	Precision Medicine 11/2020 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2016
1	Enzyme Replacement Therapy 04/2015
1	Intranasal Administration 07/2013
1	Nutritional Support (Artificial Feeding) 12/2006